Further delays and
funding uncertainty for much - needed transportation projects, particularly those that allow communities to grow and contribute to walkable, stable, and vibrant neighborhoods, may negatively affect property values and inhibit development.
Not exact matches
Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential
for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences
for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic
uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals
for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand
for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional
funds or refinance debt, including our ability to obtain the debt to finance the purchase price
for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate
for our additional capital needs or
for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions
for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
Many great companies sat out the IPO market last year
for a myriad of reasons, including the abundance of private capital,
funds flow out of conventional
funds ($ 224 billion in outflows, to be exact), and more «blackout» windows than normal — post-Brexit and post-Trump in particular — where companies were afraid of political
uncertainty.
These risks and
uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues
for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement
for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of
funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications
for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all,
for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Such risks and
uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including with respect to the Merger; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions and / or guaranty
fund assessments;
uncertainties surrounding participation in government - sponsored programs such as Medicare; the effectiveness and security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required
for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger; effects on the businesses as a result of
uncertainty surrounding the proposed Merger; as well as more specific risks and
uncertainties discussed in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.express-scripts.com.
Of the top 10 challenges identified by the report, we consider poor user experience, safety of
funds, and regulatory concerns leading to regulatory
uncertainty to be the most damaging
for Bitcoin's near - term success.
-LRB-...) A person close to SAC said the
fund had chosen settlement over two to three years of civil litigation that would follow the trial of Mr Martoma, threatening prolonged
uncertainty for investors and staff of the hedge
fund.
David Kelly, JPMorgan
Funds global strategist, said a stay vote would certainly be good
for assets because it reduces
uncertainty and returns markets to the status quo.
Though many start - ups say they are trying their best to align with US securities regulations when issuing digital tokens
for fund raising,
uncertainty continues to permeate the marketplace.
The International Monetary
Fund (IMF) has slashed its growth outlook
for the world's No. 1 and No. 5 economies, citing political pressures and fiscal
uncertainty in...
Examples of these risks,
uncertainties and other factors include, but are not limited to the impact of: adverse general economic and related factors, such as fluctuating or increasing levels of unemployment, underemployment and the volatility of fuel prices, declines in the securities and real estate markets, and perceptions of these conditions that decrease the level of disposable income of consumers or consumer confidence; adverse events impacting the security of travel, such as terrorist acts, armed conflict and threats thereof, acts of piracy, and other international events; the risks and increased costs associated with operating internationally; our expansion into and investments in new markets; breaches in data security or other disturbances to our information technology and other networks; the spread of epidemics and viral outbreaks; adverse incidents involving cruise ships; changes in fuel prices and / or other cruise operating costs; any impairment of our tradenames or goodwill; our hedging strategies; our inability to obtain adequate insurance coverage; our substantial indebtedness, including the ability to raise additional capital to
fund our operations, and to generate the necessary amount of cash to service our existing debt; restrictions in the agreements governing our indebtedness that limit our flexibility in operating our business; the significant portion of our assets pledged as collateral under our existing debt agreements and the ability of our creditors to accelerate the repayment of our indebtedness; volatility and disruptions in the global credit and financial markets, which may adversely affect our ability to borrow and could increase our counterparty credit risks, including those under our credit facilities, derivatives, contingent obligations, insurance contracts and new ship progress payment guarantees; fluctuations in foreign currency exchange rates; overcapacity in key markets or globally; our inability to recruit or retain qualified personnel or the loss of key personnel; future changes relating to how external distribution channels sell and market our cruises; our reliance on third parties to provide hotel management services to certain ships and certain other services; delays in our shipbuilding program and ship repairs, maintenance and refurbishments; future increases in the price of, or major changes or reduction in, commercial airline services; seasonal variations in passenger fare rates and occupancy levels at different times of the year; our ability to keep pace with developments in technology; amendments to our collective bargaining agreements
for crew members and other employee relation issues; the continued availability of attractive port destinations; pending or threatened litigation, investigations and enforcement actions; changes involving the tax and environmental regulatory regimes in which we operate; and other factors set forth under «Risk Factors» in our most recently filed Annual Report on Form 10 - K and subsequent filings by the Company with the Securities and Exchange Commission.
The Global Economic Policy
Uncertainty (EPU) Index is calculated as the GDP - weighted average of monthly EPU index values
for the U.S., Canada, Brazil, Chile, the U.K., Germany, Italy, Spain, France, the Netherlands, Russia, India, China, South Korea, Japan, Ireland and Australia, using GDP data from the International Monetary
Fund's (IMF) World Economic Outlook Database.
With just over a week to go before the budget deadline, Cuomo
for the first time hinted that the spending plan might not be completed on time because of the
uncertainty about future federal
funding.
Gov. Andrew Cuomo is warning that the state might not be able to add more money
for schools this year because of
uncertainties in Washington over federal
funding.
The groups say all the
uncertainty over when the
funds for supportive housing will finally be released is making it harder to plan
for any future housing projects, while the number of homeless New Yorkers is growing.
Cuomo sought to blame «ultraconservatives» in Washington late Sunday night
for the
uncertainty in federal
funding that flows to New York.
Cuomo also says the state budget, which is due next week, may now be held up over the
uncertainty over federal
funding for health care and other items.
Democratic lawmakers who represent upstate New York cities called on Wednesday
for $ 12 million in state
funding to bolster refugee re-settlement efforts amid
uncertainty over the federal ban on migration to the United State.
«In this period of austerity, national economic
uncertainty, unpredictability of federal
funding, and rising social service costs there is an increasing risk that
funding for infrastructure investments will be curbed to dangerous levels,» Ravitch said in a press release.
Governor Andrew Cuomo is warning that New York might not be able to add more money
for schools this year because of
uncertainties in Washington over federal
funding.
The battle
for increased reimbursement will play out over the next 90 days as the budget is negotiated, and against the backdrop of a state - imposed Medicaid cap,
uncertainty over the future of federal Medicaid
funding and cries from long - term care facilities and home health care providers, which are also pleading
for higher reimbursements.
Four million New Yorkers will have to re-enroll
for their health insurance starting Nov. 1 amid
uncertainty over the future of the federally
funded program.
The education secretary's statement recognises plans
for major reform to
funding for schools and academies has already provoked anxiety and
uncertainty
The Chairman of the Coalition, Bright Appiah, speaking on Eyewitness News, said that while government is justified in its attempts to diversify
funding for the free SHS programme, the
uncertainty surrounding the creation of the voluntary
fund could be detrimental to its implementation.
The absence of a policy document
for the Akufo - Addo government's free SHS policy has in the past been noted as contributing to
uncertainties about the timelines, source of
funding and scope of the policy.
With the proposed UFT contract settlement eliminating many
uncertainties, Mayor Bill de Blasio on May 8 presented a balanced executive budget
for next year that included significant new
funding for arts education and after - school programs.
«While Gov. Walker spends millions of taxpayer dollars making it harder
for working families to put food on the table, Wisconsin communities continue to struggle with crumbling roads, school
funding cuts and economic
uncertainty,» Democratic Senate Minority Leader Jennifer Shilling tweeted on Tuesday.
Governor Cuomo is warning that the state might not be able to add more money
for schools this year, because of
uncertainties in Washington over federal
funding.
Biomedical researchers are beset by low morale and high
uncertainty, along with
funding swings that economists say make
for an inefficient research enterprise.
«As a result, the influence of external activities such as consulting or speaking fees, research grant
funding and stock ownership has the potential to create significant bias and
uncertainty for issued recommendations.»
► In this week's issue of STM, Arthur Levine, senior vice chancellor
for the health sciences and dean of the University of Pittsburgh School of Medicine in Pennsylvania, and 18 other U.S. academic medical center leaders wrote that «[u] nstable
funding for biomedical research has created a hostile working environment that erodes the time available
for investigators to conduct their research, discourages innovative high - risk science, threatens to drive established investigators out of U.S. academic biomedical research, and creates
uncertainty for trainees and early - career investigators.
Given such
uncertainties, Bush, much like his father a decade earlier, pledged additional
funding for climate studies.
A recent study in the Journal of Environmental Management carried out by researchers at the European Forest Institute and their partners in the FP7
funded MOTIVE project (Models
for Adaptive Forest Management) discusses how forest managers and decision makers can cope with climate
uncertainties.
«Given the current
uncertainty about FY [fiscal year] 2017
funding, the Census Bureau will not continue expending resources to prepare
for the FY 2017 field tests, only to receive insufficient resources to conduct them,» her memo reads.
And the financial
uncertainty will continue as Congress continues to try to agree on a long - term plan
for funding government operations.
Ongoing
uncertainty over the impact of the
funding cuts means that many universities haven't yet set their postgraduate charges
for 2012.
Should graduate students and postdocs hoping
for careers — or even jobs — in academe be exploring other options because of the
uncertainties created by the across - the - board federal
funding cuts known as sequestration?
For science itself, the year 2005 had its share of headline - grabbing triumphs and controversies, but for scientists and science trainees planning their careers, the year offered mostly more of the same: the usual job - market uncertainties, a continuing scramble for research funds (which during the year became increasingly scarce), and more studies by important policy bodies aimed at increasing the number of scientists our nations produ
For science itself, the year 2005 had its share of headline - grabbing triumphs and controversies, but
for scientists and science trainees planning their careers, the year offered mostly more of the same: the usual job - market uncertainties, a continuing scramble for research funds (which during the year became increasingly scarce), and more studies by important policy bodies aimed at increasing the number of scientists our nations produ
for scientists and science trainees planning their careers, the year offered mostly more of the same: the usual job - market
uncertainties, a continuing scramble
for research funds (which during the year became increasingly scarce), and more studies by important policy bodies aimed at increasing the number of scientists our nations produ
for research
funds (which during the year became increasingly scarce), and more studies by important policy bodies aimed at increasing the number of scientists our nations produce.
And the financial
uncertainty will continue as Congress continues to try to agree on a long - term plan
for funding government operations,» Malakoff writes.
Now, if by impacts, he means the impacts to ecosystems, etc., it seems unlikely that climate scientists jockeying
for funding would be trying to change the topic of interest from climate science to these other fields (which I guess gets back to your point that
funding self - interest would dictate continuing to emphasize
uncertainty).
Because, despite having this breadth of knowledge within its walls, and
for many years after these climate science programs were run at Exxon, the company has spent years and millings of dollars
funding climate deniers and think tanks who attack the scientific consensus, spreading doubt and
uncertainty.
Nevertheless, the
uncertainty about the program's future drove away potential donors, thereby limiting the amount of
funds available
for scholarships.
There can be
uncertainty between schools and local authorities as to who is ultimately responsible
for the management of asbestos, although the legally responsible duty holder is usually the employer or the provider of delegated
funding.
There has never been a worse time
for there to be
uncertainty over how the training of future educational psychologists will be
funded.
«At a time when students are increasingly hesitant about their prospects in the job market, and schools and universities face
uncertainty when it comes to securing
funding, there is a need
for solid evidence to inform crucial decisions and shape future policies», Jane adds.
Murillo fears the new program could have devastating consequences, leading to disruption of
funding and
uncertainty for administrators who will not know how to plan their budgets.
But there is
uncertainty over the Conservatives» manifesto promise
for an extra # 1bn per year, as that depended on
funding from scrapping universal infant free meals - a proposal which is no longer confirmed.
With fiscal constraint continuing and macroeconomic
uncertainty, this approach suggests there while there is a greater appetite
for targeted interventions within current budgets, blanket increases to teacher pay
funded with new money are unlikely.
«With budgets already stretched, and
uncertainty about future
funding, ASCD is sensitive to the challenges school leaders face when making financial decisions
for their staff and students,» said Deb Delisle, ASCD Executive Director and CEO.
According to Wade Henderson, president and CEO of The Leadership Conference on Civil and Human Rights and The Leadership Conference Education
Fund, the recent rollback of the ESSA regulations «has led to more confusion and
uncertainty for states who are in the middle of drafting...